Hemolytic-Uremic Syndrome clinical trials at UCSF
1 research study open to eligible people
Hemolytic-uremic syndrome is a rare illness that harms the blood and kidneys. UCSF is conducting a study to test Crovalimab in people with atypical hemolytic-uremic syndrome. The research focuses on the drug's safety and how it affects the body.
Showing trials for
Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
open to eligible people ages 12 years and up
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
San Francisco, California and other locations
Last updated: